Table 1 Clinical parameters of MM patients.
Patient no. | Sex/Age | Clinical stage | Monoclonal Ig | % PCs in BM |
|---|---|---|---|---|
1 | M/62 | Onset | IgG-k | 42% |
2 | F/59 | Onset | IgA-k | 51% |
3 | M/68 | Relapse | IgG-λ | 31% |
4 | F/74 | Relapse | IgG-λ | 47% |
5 | M/56 | Onset | IgG-k | 8% |
6 | F/83 | Relapse | IgG-k | 38% |
7 | F/79 | Relapse | IgG-λ | 46% |
8 | M/89 | Onset | IgG-k | 50% |
9 | F/61 | Onset | IgG-k | 37% |
10 | F/72 | Onset | IgG-k | 48% |
11 | F/78 | Progression | IgG-k | 8% |
12 | M/71 | Relapse | IgG-k | 61% |
13 | F/76 | Onset | IgG-λ | 62% |
14 | F/82 | SMM | IgA-λ | 19% |
15 | F/70 | Onset | micro-k | 38% |
16 | F/53 | Onset | IgG-λ | 32% |
17 | F/82 | Onset | IgA-λ | 35% |
18 | F/82 | Relapse | IgG-k | 23% |
19 | F/70 | Onset | micro-λ | 24% |
20 | F/65 | Relapse | IgG-k | 65% |
